Marc Scheineson is quoted on how legal actions by the U.S. Food and Drug Administration against stem cell clinics are shaping regenerative medicine regulations.
In the News
August 3, 2018
Bloomberg Law | Stem Cell Clinics Face Long Odds against FDA in Legal Fight
Media Contact